Abstract . Advanced tumor growth requires the formation of new blood vessels (angiogenesis). Whether new blood vessels are formed or not depends on a balance between angiogenesis inhibitors and promoters. Host tissue, as well as tumor cells, express inhibitory factors preventing angiogenesis. During cancer progression, tumor cell lines evolve which produce factors promoting the angiogenic switch. We use mathematical models in order to examine the conditions required for angiogenic cell lines to emerge and hence for the disease to progress.
Cancer progression and angiogenesis
Cancer progression is a multi-stage process. It involves an accumulation of mutations and an expansion of mutant lineages leading to incremental increases in tumor size, a transition from a benign to a malignant state, metastasis and disease pathology (1, 2) . A typical characteristic of cancer cells is the phenomenon of genetic instability (1, 2) . Genetic instability can be defined as an increase in the rate of mutation caused by corruptions in checkpoint genes that normally ensure faithful replication of the genome. The relevance and role of genetic instability for cancer progression remains unclear. The elevated rate of mutation effectively reduces the overall replication rate of the tumor cell population (1) . This is because a high mutation rate results in a reduced number of viable daughter cells. If the mutation rate lies beyond a certain threshold, the tumor population risks extinction. Hence, in this context, genetic instability reduces the fitness of the tumor.
In order to better understand the role of genetic instability in cancer progression, we have to take into account the selective forces and host defenses that oppose tumor growth. Relatively little is known about such host defenses, and several possibilities have been considered. Given that cancer cells display tumor-specific antigens, it is becoming increasingly clear that the immune system can fight tumors, especially when induced by therapeutic approaches (3, 4) . On the other hand, with many types of cancers, the role of the immune system in the natural history of tumor progression remains uncertain (5) . Another host defense mechanism that has received a lot of attention is the limitation of blood supply (inhibition of angiogenesis), restricting tumor growth beyond a small size (6) . Whether new blood vessels are formed or not depends on a balance between angiogenesis inducers and angiogenesis inhibitors. Normal host tissue, as well as genetically altered cells, express angiogenesis inhibitors that prevent the formation of new blood vessels. This in turn prevents tumors from growing and progressing. Angiogenesis inhibitors have also received attention from a therapeutic point of view, especially angiostatin and endostatin (7) . Tumor cells that do have the capacity to grow and progress express factors that promote the formation of blood vessels (angiogenesis promoters). The evolution of angiogenic tumor cells is an important step in tumor progression, marking the transition from a small and dormant tumor to a growing tumor with the potential to cause pathology.
The interactions between angiogenesis inhibitors and promoters expressed by normal host cells and tumor cells are multi-factorial and non-linear. Hence, mathematical models can help us to gain a better understanding about the conditions under which tumors can grow and become pathogenic, and under which circumstances small tumors remain contained and controlled. The models highlight the important correlation between genetic instability and the promotion of angiogenesis. The models suggest that genetic instability in tumor cells is required initially, to overcome the inhibition of angiogenesis. Subsequently, genetic instability becomes a disadvantage in the long-term.
Conditions for the emergence of angiogenic cell lines
We construct and analyze a model for the evolution of angiogenic tumor cell lines. The model consists of three basic variables (Fig. 1) . Healthy host tissue, x 0 ; a first transformed cell line, x 1 , which is non-angiogenic and cannot grow above a given threshold size; an angiogenic tumor cell line which has the potential to progress, x 2 . It is thought that the formation of new blood vessels depends on a balance of angiogenesis inhibitors and promoters. If the balance is in favor of the inhibitors, new blood vessels are not formed. On the other hand, if it is in favor of the promoters, angiogenesis can proceed. Hence, the model assumes that healthy tissue, x 0 , and stage one tumor cells, x 1 , produce a ratio of inhibitors and promoters that is in favor of angiogenesis inhibition. On the other hand, it is assumed that angiogenic tumor cell lines have the ability to shift the balance in favor of angiogenesis promotion. We firstly consider progression from the wild-type cells to a first transformed cell line. The basic model is given by the following pair of differential equations:
Healthy cells are assumed to replicate at a density dependent rate r 0 x 0 (1-x 0 /k 0 ). The value of k 0 represents the maximum size this population of cells can achieve, or the carrying capacity. The cells die at a rate d 0 x 0 . We assume that the rate of mutation is proportional to the rate of replication of the cells, and is thus given by µ 0 r 0 x 0 (1-x 0 /k 0 ). The mutation gives rise to the first stage of tumor progression, x 1 , i.e. to a tumor cell line that is not angiogenic. This cell line will depend on the blood supply of the healthy tissue and will not be able to grow significantly and attain only a small size. These cells replicate at a density dependent rate r 1 x 1 (1-x 1 /k 1 ), where the carrying capacity k 1 is assumed to be relatively small (k 1 <<k 0 ). They die at a rate d 1 x 1 , and mutate to give rise to an angiogenic tumor cell line, x 2 , at a rate µ 1 r 1 x 1 (1-x 1 /k 1 ). In the model, the population of healthy cells attains a homeostatic setpoint given by x 0 * =k 0 (r 0 -d 0 )/r 0 . The mutation rate µ 0 can be assumed to be very small, since healthy tissue has intact repair mechanisms that ensure faithful replication of the genome. Once mutation gives rise to a the first tumor cell line, it will grow to its small homeostatic set point level defined by x 1 * =k 1 (r 1 -d 1 )/r 1 . The wild-type cell population and the small population of first stage tumors are assumed to reach constant levels in a relatively short time. In other words, they reach an equilibrium abundance. Further tumor growth requires the emergence of the angiogenic cell line, x 2 . In the following we investigate the conditions required for angiogenic tumor cell lines to evolve assuming a constant background abundance of x 0 and x 1 .
The angiogenic cell line replicates at a density dependent rate r 2 x 2 (1-x 2 /k 2 ). As these cells can potentially influence the balance of inhibitors and prompters in favor of promoters, we have to take these dynamics into account. Hence, the death rate of these cells is determined by two components. The angiogenic tumor cells are characterized by a composite background death rate d 2 x 2 as with x 0 and x 1 . In addition, the model assumes that the death rate can be increased if the balance between angiogenesis inhibition and promotion is in favor of inhibition. Hence, this death rate is expressed as (p 0 x 0 +p 1 x 1 +p 2 x 2 )/(qx 2 +1). Thus all three cell types lead to the inhibition of angiogenesis, whereas inhibition of angiogenesis can only be overcome by cell line x 2 .
As we have assumed that x 0 and x 1 are at equilibrium, we start our analysis by ignoring mutation and simply looking at the dynamics of the angiogenic cell line, x 2 . These dynamics are described by: where x 0 * and x 1 * are defined above. Two outcomes are possible: i) the cell line x 2 cannot invade, resulting in where subscript I refers to the inhibitory cell lines: p I x I = p 0 x 0 * +p 1 x 1 * . In the following we examine the stability properties of these two equilibria which are summarized in Fig. 2 . If p I x I <r 2 -d 2 , then the equilibrium describing the extinction of the angiogenic tumor, x 2 (0) , is not stable. The equilibrium describing the invasion of the angiogenic tumor cell line, x 2 (1) , is stable. In other words, if the above condition is fulfilled, then the degree of angiogenesis inhibition is too weak, and the angiogenic tumor cell line can emerge, marking progression of the disease.
On the other hand, if p I x I >r 2 -d 2 , the degree of inhibition is stronger and the situation is more complicated (Fig. 2) . The equilibrium describing the extinction of the angiogenic cell population, x 2 (0) , becomes stable. However, equilibrium x 2 (1) , describing the emergence of angiogenic tumor cells, may or may not be stable ( Fig. 2 ): i) if the degree of angiogenesis inhibition lies above a certain threshold and is very strong, equilibrium x 2 (1) is unstable and the angiogenic cell line cannot invade. It was not possible to define this threshold in a mathematically meaningful way; ii) if the degree of angiogenesis inhibition lies below this threshold and is thus intermediate, equilibrium x 2 (1) remains stable. Now, both the extinction and the emergence equilibria are stable (Fig. 2 ). This means that two outcomes are possible and that the outcome depends on the initial conditions. Either the angiogenic cell line fails to emerge, or the angiogenic cell line does emerge, resulting in tumor progression. As shown in Fig. 3 , a low initial abundance of angiogenic tumor cells results in failure of growth. On the other hand, a high initial number of angiogenic tumor cells results in growth of the tumor and progression (Fig. 3) .
To summarize, the model shows the existence of three parameter regions (Fig. 2) . If the degree of angiogenesis inhibition by healthy tissue and stage one tumor cells lies below a threshold, angiogenic tumor cell lines always invade resulting in progression of the disease. If the degree of inhibition lies above a threshold, the angiogenic cell lines can never emerge and pathology is prevented. In between these two thresholds, both outcomes are possible depending on the initial conditions. A high initial number of angiogenic tumor cells results in growth of this cell line and progression of the disease.
What does the initial number of angiogenic cells mean in biological terms? The initial number of these cells can be determined by the mutation rate µ 1 , which gives rise to the angiogenic cells. If the mutation rate is high, the initial number of angiogenic cells will be high. On the other hand, if the mutation rate is low, the initial number of the angiogenic cells will be low. Hence, in the parameter region where the outcome of the dynamics depends on the initial conditions, a high mutation rate promotes the emergence and growth of angiogenic tumor cells (Fig. 4) . If a high mutation rate by tumor cells defines genetic instability, then we conclude that genetic instability might be required for the invasion of angiogenic tumor cells.
The devolution of genetic instability
The last section gave rise to the result that the emergence of angiogenic tumor cell lines, and hence progression of disease, can require genetic instability. This is because before angiogenic tumor cell populations can become established, cells have to emerge that are characterized by less faithful replication and hence a higher mutation rate. However, once this founder population of cells has fixed, it will have to persist within a large population of similarly angiogenic tumor cells which are expected to be polymorphic in their degree of genetic instability. Within this space, the tumor cells are likely to be in competition with each other. Hence, for a genetically unstable cell line of a given degree of genetic fidelity to persist, it has to be competitively superior relative to both the more stable cells and the less stable cells. For the sake of clarity we can simplify things somewhat by assuming that both inhibition and promotion of angiogenesis operate through one death rate term and that there are only two cell lineages present in the population with two levels of genetic instability. These competition dynamics can be captured by the following pair of equations:
The variable y 1 represents a more genetically stable cell line, while the variable y 2 represents a genetically less stable cell line. Both populations compete within a limited space, defined by the carrying capacity, k. The cells replicate at a rate r i and die at a rate d i . During replication, the cells mutate at a rate µ i . Since y 2 represents the more genetically unstable population of cells, it is assumed that µ 2 >>µ 1 .
In the model, one of the two populations of cells will survive and outcompete the other. The population of genetically unstable cells, y 2 , will survive if r 2 /d 2 >(r 1 -µ 1 )/{(1-µ 2 )[µ 1 (r 1 -1) +d 1 ]}. If this condition is not fulfilled the genetically stable cell line survives. If we make the realistic assumption that the mutation rate of the stable cell line is very low, then the condition for the survival of the unstable cells, y 2 , can be approximated by r 2 /d 2 (1-µ 2 )>r 1 /d 1 . This shows that genetic instability carries a cost, and that this cost must be compensated for by a higher growth rate of the genetically unstable tumor cell population, y 2 . This can be achieved either by a higher rate of cell division, r 2 , or by a reduced rate of cell death or apoptosis, d 2 . The higher the degree of genetic instability, the higher the increase in the overall growth rate of this cell population required for its emergence.
To summarize, in order to persist as an unstable cell lineage, genetic instability must be accompanied by an increase in the overall growth rate of the cell. This might either require more than one mutational event in the same cell, or one mutation that influences both the accuracy of replication and the rate of growth. If this growth progression does not occur, then in time, angiogenic cell lineages are predicted to restrict or reduce their degree of genetic instability. Factors that could promote the emergence and maintenance of genetic instability will be considered in the discussion.
Thoughts on angiogenesis and genetic instability
The controversy about genetic instability. Tumor growth and cancer progression is the result of an accumulation of mutations in genes that control the cell cycle. At the same time, there is evidence that most cancers are characterized by a relatively high rate of mutation. That is, they are genetically unstable. Two types of genetic instability have been identified in cancers (2) . In most cases, the instability is observed at the chromosomal level. This involves gains and losses of whole chromosomes and has been called chromosomal instability or CIN. In a few cases, the instability is at the nucleotide level, resulting from failure of DNA repair. This is referred to as nucleotide excision repair associated instability (NIN) and microsatellite instability (MIN). Recently, it has been suggested that genetic instability is the primary force driving the process of tumor progression (8, 9) . According to these arguments, the somatic mutation rate is too low to account for the incidence of mutations observed in cancer cells. Hence, a mutator phenotype is required. On the other hand it has been argued that selection, and not mutation, is the primary force driving tumor progression (10) (11) (12) . While genetic instability is observed in most clinical cancers and can speed up the rate of evolution, a high mutation rate is not always present in the initiation and progression of tumors. From this discussion it is becoming clear that the role of genetic instability in tumor progression is controversial. In particular, it remains an open question why genetically stable tumors and cancers are not observed more often. A higher rate of mutation reduces the effective replication rate of the cells and hence confers a selective disadvantage. Cells that have gained a growth advantage without becoming genetically unstable should be selectively superior. Such a growth advantage could be achieved by simple mutations that reduce the death rate of the cells (e.g. by reducing the rate of apoptosis), or that increase the replication rate of the cells (e.g. by making them less dependent on growth factors).
Genetic instability and angiogenesis. In this study, we used mathematical models to further investigate the relevance of genetic instability in tumor progression. The models suggest that genetic instability might be required for the emergence of angiogenic tumor cell lines. Emergence of angiogenic cells in turn enables the tumor to grow to larger sizes and to progress towards a more malignant state. In the absence of genetic instability, angiogenic tumor cell lines cannot grow, even if the relevant mutations are generated at low levels in the population of cells. The reason is as follows: host tissue cells and early tumor cells induce a ratio of angiogenesis inhibitors and promoters that is in favor of inhibition. The balance can be altered by new mutations in the tumor cells. However, the balance can only be shifted significantly to overcome inhibition if a sufficient number of cells expressing the angiogenic phenotype are generated within a short enough period of time. A sufficient initial number, or founder population, of angiogenic tumor cells can be created if the mutation rate of the cells is relatively high. That is, if the cells are genetically unstable. Thus, the model suggests that genetically stable tumor cells cannot grow and progress beyond a certain size because angiogenic cells cannot invade. This could be a mechanism contributing to the relatively high degrees of genetic instability observed in clinical cancers.
A note of caution: in theory, a single cell could shift the balance in favor of angiogenesis if it were able to promote the formation of blood supply at a high enough rate sufficient to overcome the inhibitory factors produced by the population of wild-type cells. However, it is unlikely that a single cell could overcome the inhibitory effects induced by tissue and tumor cells. The less effective each angiogenic cell is at shifting the balance, the greater genetic instability is required for the emergence of such cell lines.
The emergence and maintenance of genetic instability. While this argument can suggest a possible role for genetic instability in early tumor progression, it does not explain how genetic instability arises in the first place and how or why it is maintained in the long-term. As pointed out above, modeling suggests that once the angiogenic switch has been induced, heterogeneity in the cancer cell population could result in the selection of more stable cell lines. Some mechanisms have been proposed which could lead to selection for genetically unstable cell lines. It has been argued that in a rapidly changing environment, mutators could evolve if the ability of the cell population to adapt to new environments is limited by the availability of mutations (9, 13) . Such a situation could exist in tumor environments (1) . Other authors have proposed that the presence of carcinogens themselves lead to the selection of genetically unstable cell lines (14) . They suggested that bulky adduct forming agents (BAF) can select for CIN, while methylating agents select for MIN. In both cases, the carcinogens cause mutations which result in cell cycle arrest, following the activity of mismatch repair mechanisms or activated mitotic checkpoints (14) . Cells lacking these repair mechanisms do not enter cell cycle arrest and grow faster. There is some experimental support for this hypothesis. Bardelli et al (15) treated immortal and genetically stable cells with carcinogens. Cells resistant to a bulky adduct forming agent developed CIN, while cells resistant to a methylating agent developed MIN (15) .
Finally, as demonstrated by our model, the simplest mechanism by which genetic instability can evolve in the long-term is if the mutation conferring instability also confers a sufficient growth advantage to the cell in order to compensate for the deleterious effect originating from a high mutation rate. Similar ideas have been proposed in the literature (1, 11) . Among a number of other genes (11) , mutations in p53 are thought to have such dual effects. Related to these arguments, genetically unstable cells could be maintained at a given level by a mutation selection balance, and they might emerge to higher numbers if they generate an advantageous mutation that compensates for the reduced fitness resulting from the high mutation rate.
Tumor progression and genetic instability. These considerations give rise to the following picture of tumor progression. Initially mutations are generated that give a cell a growth advantage relative to other cells. This occurs either by a reduction in the death rate or an increase in the growth rate of the cells. Such mutated cells are likely to be genetically stable and would be selected for. However, such tumors are unlikely to progress to malignant cancers, since this requires the emergence of angiogenic cell lines. Even if mutants are produced that are angiogenic, these mutants are unlikely to invade the wild-type cell population if it is genetically stable.
First, genetic instability has to evolve. This will ensure that a sufficient number of angiogenic cell lines are created within a short period of time, allowing them to shift the balance in favor of angiogenesis which in turn results in further tumor growth. Once an angiogenic population is established there is no longer an advantage for instability. Instability becomes a liability because it reduces the number of viable daughter cells produced.
This proposed role of genetic instability in cancer progression falls between the two arguments presented above: whether genetic instability or selection is the main driving force for the evolution and progression of cancers (12, 16) . According to our reults, genetic instability is required for early cancer progression when a high mutation rate ensures that angiogenic cell lines can invade the tumor cell population. However, in the model, genetic instability is not required for the accumulation of subsequent mutations driving tumor progression.
In this context, angiogenesis inhibition can be viewed as a host defense that forces the tumor to become genetically unstable before it can grow and progress to larger sizes. The requirement for angiogenic mutants to evolve thus makes it necessary for the tumor to go through a fitness valley (a higher degree of instability) in order to avoid remaining dormant at a limited size. This makes the process of tumor progression more difficult.
Genetic instability and angiogenesis in colorectal cancer.
A well documented example of the steps involved in tumor progression is colorectal carcinogenesis. Several inherited predispositions to colorectal cancers have been identified. Two examples are familial adenomatous poliposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC). However, most colorectal cancers do not appear to have an inherited component and are called sporadic. Progression of such tumors is thought to occur through the accumulation of sequential mutations resulting in the development of a carcinoma and eventual metastatic spread (10, 16, 17) . Initiation of the tumor is induced by mutations in the adenomatous polyposis coli (APC) locus. Formation of a small neoplasm appears to require mutations in both alleles. Subsequently, additional mutations are acquired. Often, mutations occur in the K-ras gene, and later on in tumor suppressors such as 18q and p53. This accumulation of mutations eventually results in the formation of malignant cells that metastasize.
The emergence of genetic instability has been observed to occur relatively late in the process of tumor progression, for example when mutations occur in p53 or similar genes at the late adenoma/carcinoma stage (10, 18) . The transition from adenomas to carcinomas also coincides with a marked increase in micro-vessel density, indicating an angiogenic switch (19) . This is consistent with the hypothesis that genetic instability is required for the invasion of angiogenic tumor cell lines which in turn results in progression to malignancy.
Summary
We have analyzed mathematical models in order to examine the evolutionary dynamics of tumor progression with special focus on the role of angiogenesis. The models point towards a connection between the evolution of genetic instability and the emergence of angiogenic tumor cell lines: emergence of angiogenic tumor cell lines requires the existence of genetic instability. If the tumor is genetically stable, angiogenic cell lines cannot grow, even if the relevant mutants are generated. In this context, the role of genetic instability is not to enhance the evolvability of the cancer, but to increase the founder population of angiogenic mutants created from wild-type cells. This allows the mutants to grow and to invade the tumor cell population, resulting in advanced progression of the cancer. Hence, inhibition of angiogenesis can be viewed as a host defense that forces the tumor to become genetically unstable if it is to grow and progress beyond a certain size limit. Since genetic instability is likely to decrease the fitness of the tumor, the cells have to go through a fitness valley in order to be able to proliferate further.
The emergence of angiogenic cell lines might not be the only evolutionary event facilitated by genetic instability. Genetic instability might be required for the growth of any mutant whose ability to fix in a population depends on the initial conditions. In general, this is likely to be the case if the mutant produces certain factors which have to balance out other factors produced by the host tissue as a defense against increased cancerous growth.
While the central result of our models state that the emergence of angiogenic tumor cell lines requires genetic instability, the mechanisms by which genetic instability evolves and is maintained remains uncertain. Several possibilities have been discussed, and mathematical models can provide some guidance when examining these in greater detail.
